2019 American Transplant Congress
Impact of Vancomycin-Resistant Enterococci Gut Colonization on Liver Transplant Outcomes
University of Alberta, Edmonton, AB, Canada
*Purpose: Vancomycin-resistant enterococci (VRE) colonization is common in liver transplant candidates. In addition to the risk of invasive enterococcal infections, dominance of VRE colonization in…2019 American Transplant Congress
Kidney Transplantation in Older Recipients with HLA-DR Mismatch: Impact of Induction Type on Outcomes
*Purpose: In kidney transplantation, donor-recipient HLA-DR mismatch signals high immunologic risk and can result in poor transplant outcomes. Older kidney transplant recipients (KTRs) are more…2019 American Transplant Congress
Treatment of Cardiovascular Risk Factors Improves Long Term Outcome Post Liver Transplantation
Washington University in St Louis, Saint Louis, MO
*Purpose: Cardiovascular (CV) disease is a leading cause of mortality 1 year after liver transplantation (LT). We aimed to assess the effect of treating CV…2019 American Transplant Congress
A National Cohort Validation of Graft Outcomes of Elderly Kidney Transplant Recipients
Henry Ford Transplant Institute, Detroit, MI
*Purpose: Previous analyses comparing elderly kidney transplant recipients (KTR) to younger KTR found that elderly patients suffered higher rates of mortality, less biopsy-proven acute rejection…2019 American Transplant Congress
Impact of MELD-Na Course (Delta MELD-Na) on Outcome after Liver Transplantation
*Purpose: Currently, MELD Score listing is state of the art for liver transplant recipients. Our department could show by our own institutional data and confirmed…2019 American Transplant Congress
Initial Single-Center Results from the Pilot Transplant Quality Improvement Project in Liver Transplant
UC San Francisco, San Francisco, CA
*Purpose: The National Surgical Quality Improvement Program (NSQIP) has been an effective measure in improving the quality of surgical care, while also providing data to…2019 American Transplant Congress
Multicenter Experience Evaluating Outcomes of HCV-Seropositive Donors to HCV-Seronegative Recipients Liver Transplantation
*Purpose: Grafts from hepatitis C virus (HCV)-seropositive donors can now be considered for liver transplant (LT) due to the advent of direct-acting antiviral agents (DAA).…2019 American Transplant Congress
Pathologic Vascular Invasion Correlates with Worse Outcome in Hepatoblastoma Patients Treated with Liver Transplantation – A Hepatoblastoma Transplant Consortium Study
*Purpose: Orthotopic liver transplant (OLTx) is the most common method to treat unresectable hepatoblastoma (HB) in children. There is limited data focusing on the outcomes…2019 American Transplant Congress
Center Variability in Organ Offer Acceptance and Waitlist Mortality in Lung Transplantation
*Purpose: Lung transplantation (LTx) offers a survival benefit for patients with end-stage lung disease. When suitable donors are identified, centers must accept or decline the…2019 American Transplant Congress
Simultaneous Pancreas and Kidney Transplant Outcomes after Induction Therapy with Thymoglobulin Compared with Alemtuzumab
*Purpose: The purpose of this study is to compare the outcomes of simultaneous pancreas and kidney transplant (SPK) recipients after two T-cell depleting induction agents:…
- « Previous Page
- 1
- …
- 64
- 65
- 66
- 67
- 68
- …
- 155
- Next Page »